Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

AKTS

Aktis Oncology, Inc.

CIK 0002035832 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$24.07
↑ 0.07 (0.29%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 2/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Technicals; Excluded: Fundamentals, Options (no data)

Key stats

Market Cap
$1.29B
P/E Ratio
Not covered
EPS
Not covered
Dividend Yield
Not covered
52W Position
48%
Beta
1.61

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
2.67
P/S
Not covered
EV/Revenue
Not covered
ROE
Not covered
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

155 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 48%
$14.72$34.19

Latest Financials

–
Revenue
–
Net Income
–
Total Assets
–
Free Cash Flow
–

Recent news